These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 24401679

  • 21. Production and characterization of monoclonal antibodies against 17alpha-hydroxyprogesterone.
    Chong H, Cheah SH, Ragavan M, Johgalingam VT.
    Hybridoma (Larchmt); 2006 Feb; 25(1):34-40. PubMed ID: 16475880
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Reference intervals for serum 17α-hydroxyprogesterone and ultrasonographic adrenal gland sizes in healthy newborns.
    Karagüzel G, Eyüboğlu İ, Özdem S, Kader Ş, Kaya S, Beyhun NE.
    J Matern Fetal Neonatal Med; 2020 Dec; 33(23):3998-4003. PubMed ID: 30864869
    [Abstract] [Full Text] [Related]

  • 24. Liquid chromatography-tandem mass spectrometric method for determination of salivary 17alpha-hydroxyprogesterone: a noninvasive tool for evaluating efficacy of hormone replacement therapy in congenital adrenal hyperplasia.
    Shibayama Y, Higashi T, Shimada K, Kashimada K, Onishi T, Ono M, Miyai K, Mizutani S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May 01; 867(1):49-56. PubMed ID: 18378505
    [Abstract] [Full Text] [Related]

  • 25. Serum 17alpha-hydroxyprogesterone concentrations during the reproductive cycle in healthy dogs and dogs with hyperadrenocorticism.
    Brömel C, Feldman EC, Davidson AP, Nelson RW, Kass PH, Esteller Vico A, Labelle P, Munro CJ, Conley AJ.
    J Am Vet Med Assoc; 2010 Jun 01; 236(11):1208-14. PubMed ID: 20513199
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of three commercial assays for the measurement of 17alpha-hydroxyprogesterone (17alpha-OHPR): limitations of the quality control system.
    Meier U, Schnabel C, Kunz D, Driesch R, Gressner AM.
    Clin Chem Lab Med; 2004 Apr 01; 42(4):450-4. PubMed ID: 15147157
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
    Hayashi G, Faure C, Brondi MF, Vallejos C, Soares D, Oliveira E, Brito VN, Mendonca BB, Bachega TA.
    Arq Bras Endocrinol Metabol; 2011 Nov 01; 55(8):632-7. PubMed ID: 22218447
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.